Cancer Biology Program Students
Year you started the UC Denver Cancer Biology Program:
Why you chose the UC Denver Cancer Biology Program:
When I was looking at different schools, I liked the diverse areas of research accessible in the cancer biology program at UC Denver. I felt that I could explore my different interests during my rotations.
What labs you rotated in:
Doug Graham, MD PhD
Lynn Heasley, PhD
Cheng-Jun Hu, PhD
What lab you joined and why:
Lynn Heasley’s lab because throughout my first year I came to acknowledge modified signaling as a common theme in cancer progression; and I was drawn to the lab’s use of both cellular and molecular techniques.
Description of your project:
My project involves looking at signaling pathways in NSCLC, particularly the family of FGF tyrosine kinase receptors.
Marek, L., K. E. Ware, et al. (2009). "Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells." Mol Pharmacol 75(1): 196-207.
Kono, S. A., M. E. Marshall, K. E. Ware, L. E. Heasley (2009). "The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer." Drug Resist Updat 12(4-5): 95-102.
Keating, A. K., G. K. Kim, A. E. Jones, A. M. Donson, K. Ware, et al. (2009). "Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity." Mol Cancer Ther 9(5): 1298-307.
Where you attended undergraduate and what your major / minor(s) were:
Louisiana State University
What you did (if anything) between undergraduate and graduate school:
I worked as a research associate in a microbiology lab for half a year.
What you like to do outside of school:
Camping, snowboarding, good food and hanging out with my dog Riley.
What is your favorite thing about Colorado:
Seeing the mountains everyday.